These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 25719943)
1. Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway. Mu Q; Wang L; Yu F; Gao H; Lei T; Li P; Liu P; Zheng X; Hu X; Chen Y; Jiang Z; Sayari AJ; Shen J; Huang H Cancer Biol Ther; 2015; 16(4):623-33. PubMed ID: 25719943 [TBL] [Abstract][Full Text] [Related]
2. Downregulating DNA methyltransferase 3B by suppressing the PI3K/Akt signaling pathway enhances the chemosensitivity of glioblastoma to temozolomide. Kan W; Gao L; Chen J; Chen L; Zhang G; Hao B; He M; Chen X; Wang C Mol Neurobiol; 2024 Sep; 61(9):7066-7074. PubMed ID: 38368287 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT. Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036 [TBL] [Abstract][Full Text] [Related]
4. SPOCK1 is upregulated in recurrent glioblastoma and contributes to metastasis and Temozolomide resistance. Yu F; Li G; Gao J; Sun Y; Liu P; Gao H; Li P; Lei T; Chen Y; Cheng Y; Zhai X; Sayari AJ; Huang H; Mu Q Cell Prolif; 2016 Apr; 49(2):195-206. PubMed ID: 26923184 [TBL] [Abstract][Full Text] [Related]
5. Osthole inhibits insulin-like growth factor-1-induced epithelial to mesenchymal transition via the inhibition of PI3K/Akt signaling pathway in human brain cancer cells. Lin YC; Lin JC; Hung CM; Chen Y; Liu LC; Chang TC; Kao JY; Ho CT; Way TD J Agric Food Chem; 2014 Jun; 62(22):5061-71. PubMed ID: 24828835 [TBL] [Abstract][Full Text] [Related]
6. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway. Xin J; Zhang XY; Sun DK; Tian LQ; Xu P Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099 [TBL] [Abstract][Full Text] [Related]
7. BC3EE2,9B, a synthetic carbazole derivative, upregulates autophagy and synergistically sensitizes human GBM8901 glioblastoma cells to temozolomide. Chen CM; Syu JP; Way TD; Huang LJ; Kuo SC; Lin CT; Lin CL Int J Mol Med; 2015 Nov; 36(5):1244-52. PubMed ID: 26329365 [TBL] [Abstract][Full Text] [Related]
8. MiR-223/PAX6 Axis Regulates Glioblastoma Stem Cell Proliferation and the Chemo Resistance to TMZ via Regulating PI3K/Akt Pathway. Huang BS; Luo QZ; Han Y; Huang D; Tang QP; Wu LX J Cell Biochem; 2017 Oct; 118(10):3452-3461. PubMed ID: 28332226 [TBL] [Abstract][Full Text] [Related]
9. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells. Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608 [TBL] [Abstract][Full Text] [Related]
10. The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells. Atif F; Patel NR; Yousuf S; Stein DG PLoS One; 2015; 10(6):e0131441. PubMed ID: 26110872 [TBL] [Abstract][Full Text] [Related]
11. LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway. Zhong C; Chen Y; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L BMC Cancer; 2018 Jul; 18(1):722. PubMed ID: 29980193 [TBL] [Abstract][Full Text] [Related]
12. NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation. Zhang A; Peng S; Sun S; Ye S; Zhao Y; Wu Q Cancer Med; 2024 Aug; 13(16):e70100. PubMed ID: 39149873 [TBL] [Abstract][Full Text] [Related]
13. IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1. Dai N; Ji F; Wright J; Minichiello L; Sadreyev R; Avruch J Elife; 2017 Jul; 6():. PubMed ID: 28753127 [TBL] [Abstract][Full Text] [Related]
14. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines. Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244 [TBL] [Abstract][Full Text] [Related]
15. Temozolomide treatment combined with AZD3463 shows synergistic effect in glioblastoma cells. Goker Bagca B; Ozates NP; Asik A; Caglar HO; Gunduz C; Biray Avci C Biochem Biophys Res Commun; 2020 Dec; 533(4):1497-1504. PubMed ID: 33109342 [TBL] [Abstract][Full Text] [Related]
16. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells. Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502 [TBL] [Abstract][Full Text] [Related]
18. FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways. Wu Y; Dong L; Bao S; Wang M; Yun Y; Zhu R Biomed Pharmacother; 2016 Dec; 84():462-469. PubMed ID: 27685789 [TBL] [Abstract][Full Text] [Related]
19. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279 [TBL] [Abstract][Full Text] [Related]
20. SRPX2 Enhances the Epithelial-Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Cells. Tang H; Zhao J; Zhang L; Zhao J; Zhuang Y; Liang P Cell Mol Neurobiol; 2016 Oct; 36(7):1067-76. PubMed ID: 26643178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]